Projects
Single Cell Technologies (SICTEC)
Project description
Based on the success of the European research project PASCA (Platform for Automated Single Cell Handling and Analysis) the follow-up project SICTEC is further developing the Single Cell Manipulator (SCM) technology towards specific industrial applications. Embedded in the EU FP7 framework program under the call “Research for the benefit of SMEs” the SICTEC consortium consists, apart from IMTEK, of European companies from the field of life sciences. The goal of SICTEC is the realization of mass-spectroscopic analysis of single pathogens, automated patch clamping on single cells and production of high-quality monoclonal cell lines, using the SCM technology. Moreover, the technology will be further improved towards commercialization as well as specific components and integrated systems for mass spectrometry and automated patch clamp applications will be developed. In addition the preparation of a CE IVD label is planned to be able to also address diagnostic and clinical applications in the future. On behalf of the SME consortium IMTEK and Erasmus Medical Center will further optimize and validate the SCM technology, such that the SMEs can specifically improve their products and services by use of single cells subsequent to the project.
Start/End of project
01.10.2013 until 30.09.2015
Project manager
André Gross (Prof. Dr. Roland Zengerle)
Contact person
André Gross
Phone:+49 761 203-73257
Email:andre.gross@imtek.de
Partners
BioFluidix GmbH, Freiburg, D
Sophion Bioscience, Copenhagen, DK
BioSparQ, Leiden, NL
Primadiag, Paris, F
Innoprot, Derio, ES
Erasmus Medical Center, Rotterdam, NL
Funding
EU FP7
Keywords
zellbasierte Mikrosysteme, cell-based microsystems, Mikrodosierung, microdosing, InkJet & Drucktechnologien, inkjet and printing technologies